FDA Reviews Rules for Safe Drug Production Practices
Published Date: 2/20/2026
Notice
Summary
The FDA wants your thoughts on how they collect info about making and handling medicines safely, including new tech in drug manufacturing. This affects drug makers and anyone involved in producing medicines, with a comment deadline of April 21, 2026. No big costs or changes yet—just a chance to help shape future rules!
Analyzed Economic Effects
5 provisions identified: 3 benefits, 2 costs, 0 mixed.
Estimated Annual Recordkeeping Burden
FDA estimates annual recordkeeping for CGMP as 1,260 API manufacturers (322,560 records at 0.82 hours each = 264,499 hours) and 3,270 finished pharmaceuticals manufacturers (977,730 records at 0.64 hours each = 625,747 hours). The total annual records are 1,300,319 with a total annual burden of 890,455 hours.
Medical Gas Burden Removed Here
FDA removed activities and burden attributable to medical gas requirements from this collection, resulting in a decrease of 396,293 hours and 639,491 responses annually; medical gas CGMP requirements are now under OMB control number 0910-0906.
60-Day Public Comment Window
The FDA is asking for public comment on its proposed information collection related to Current Good Manufacturing Practice (CGMP) and the Advanced Manufacturing Technologies (AMT) designation program. Comments must be submitted by April 21, 2026, through https://www.regulations.gov or by mail to the Dockets Management Staff.
AMT Designation Program Burden
The Advanced Manufacturing Technologies (AMT) designation program is included in the information collection; FDA estimates 20 recordkeepers with 20 total records for AMT activities and an average burden of 10 hours per record, totaling 200 hours annually.
No Capital or O&M Costs
FDA states there are no capital or operating and maintenance (O&M) costs associated with this information collection.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11739 — Medical Devices; Immunology and Microbiology Devices; Classification of the Simple Point-of-Care Device to Directly Detect SARS-CoV-2 Viral Targets From Clinical Specimens in Near-Patient Settings
The FDA is officially putting simple COVID-19 rapid test devices into a safer, easier-to-manage category called Class II. This change means these tests can get to patients faster and with fewer hoops to jump through, while still making sure they work well and stay safe. Starting June 11, 2026, companies making these tests will follow new rules that help speed up innovation without extra costs.
2026-11740 — Medical Devices; Immunology and Microbiology Devices; Classification of the Spinal Muscular Atrophy Newborn Screening Test System
The FDA is officially putting the Spinal Muscular Atrophy (SMA) newborn screening test into class II, meaning it has special safety rules but fewer hurdles than the strictest category. This change helps make the test safer and easier to get to babies who need it, starting June 11, 2026, with the classification effective since November 2022. Labs and device makers will benefit from clearer rules and faster access, helping catch SMA early without extra costs or delays.
2026-11760 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Establishment, Maintenance, and Availability of Records; Additional Traceability Records for Certain Foods
The FDA is asking for approval to collect extra records from food businesses that handle certain high-risk foods. This helps track food sources quickly to keep everyone safe. Food companies should get ready to keep and share these new records, and comments on this plan are due by July 13, 2026.
2026-11762 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Procedures for the Safe Processing and Importing of Fish and Fishery Products
The FDA is asking for approval to keep collecting info from seafood processors and importers to make sure fish products are safe using a system called HACCP. This affects anyone who processes or imports fish and requires them to keep records showing they’re following safety rules. Comments on this plan are open until July 13, 2026, and there’s no new cost, just a continuation of current paperwork.
2026-11589 — Medical Devices; Ear, Nose, and Throat Devices; Classification of the Combined Acoustic and Electrical External Stimulation Device for the Relief of Tinnitus
The FDA has officially placed the combined acoustic and electrical external stimulation device for tinnitus relief into class II, meaning it now has special safety rules but fewer regulatory hurdles. This change helps patients get access to this innovative device faster and ensures it’s safe and effective. The new classification is effective June 10, 2026, with the rules applying retroactively from March 6, 2023.
2026-11578 — Amending Over-the-Counter Monograph M020: Sunscreen Drug Products for Over-the-Counter Human Use, and Related Information
The FDA just gave a thumbs-up to adding bemotrizinol as a new active ingredient in sunscreens, letting it be used up to 6% concentration. This means sunscreen makers can now include this ingredient, which is safe and effective, in their products. The change is official as of June 10, 2026, and could lead to better sun protection options without extra costs for consumers.
Previous / Next Documents
Previous: 2026-03325 — Overhead Door Counterbalance Torsion Springs From India; Determinations
The U.S. found that imports of overhead door counterbalance torsion springs from India are hurting American companies because they’re being sold too cheaply and getting unfair government help. As a result, special duties will be applied to these imports to protect U.S. businesses. This change affects importers and manufacturers starting soon, aiming to level the playing field and support local jobs.
Next: 2026-03327 — Public Meetings of the Advisory Committee on Landslides
The Advisory Committee on Landslides is holding public meetings on March 4-5, 2026, in Asheville, NC, and online. These meetings let experts and the public discuss landslide risks and safety plans, helping communities stay safe. If you want to join, you need to register ahead of time—no cost mentioned, but your voice matters!